Boston Common Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.96M | Sell |
13,698
-15,942
| -54% | -$5.46M | 0.29% | 92 |
|
|
2026
Q1 | $10.4M | Sell |
29,640
-3,458
| -10% | -$1.23M | 0.67% | 46 |
|
|
2025
Q4 | $10.8M | Sell |
33,098
-13,018
| -28% | -$4.13M | 0.65% | 47 |
|
|
2025
Q3 | $13M | Sell |
46,116
-1,344
| -3% | -$390K | 0.36% | 98 |
|
|
2025
Q2 | $13.3M | Sell |
47,460
-2,255
| -5% | -$639K | 0.37% | 100 |
|
|
2025
Q1 | $15.5M | Buy |
49,715
+28,004
| +129% | +$8.27M | 0.47% | 78 |
|
|
2024
Q4 | $5.66M | Buy |
21,711
+21,024
| +3,060% | +$6.24M | 0.16% | 164 |
|
|
2024
Q3 | $221K | Hold |
687
| – | – | 0.01% | 305 |
|
|
2024
Q2 | $215K | Sell |
687
-13,531
| -95% | -$3.98M | 0.01% | 307 |
|
|
2024
Q1 | $4.04M | Sell |
14,218
-14,728
| -51% | -$4.31M | 0.1% | 220 |
|
|
2023
Q4 | $8.34M | Sell |
28,946
-17,666
| -38% | -$4.81M | 0.19% | 153 |
|
|
2023
Q3 | $12.5M | Sell |
46,612
-16,140
| -26% | -$4.03M | 0.3% | 120 |
|
|
2023
Q2 | $13.9M | Sell |
62,752
-17,193
| -22% | -$3.99M | 0.3% | 123 |
|
|
2023
Q1 | $19.3M | Sell |
79,945
-2,785
| -3% | -$684K | 0.4% | 94 |
|
|
2022
Q4 | $21.7M | Sell |
82,730
-16,244
| -16% | -$4.35M | 1.04% | 29 |
|
|
2022
Q3 | $22.3M | Buy |
98,974
+5,332
| +6% | +$1.29M | 1.17% | 25 |
|
|
2022
Q2 | $22.8M | Buy |
93,642
+18,810
| +25% | +$4.61M | 1.14% | 26 |
|
|
2022
Q1 | $18.1M | Buy |
74,832
+21,883
| +41% | +$5.03M | 0.78% | 46 |
|
|
2021
Q4 | $11.9M | Buy |
52,949
+981
| +2% | +$207K | 0.48% | 68 |
|
|
2021
Q3 | $11.1M | Buy |
51,968
+278
| +0.5% | +$64K | 0.48% | 72 |
|
|
2021
Q2 | $12.6M | Sell |
51,690
-2,112
| -4% | -$520K | 0.54% | 63 |
|
|
2021
Q1 | $13.4M | Sell |
53,802
-622
| -1% | -$148K | 0.84% | 38 |
|
|
2020
Q4 | $12.5M | Buy |
54,424
+14,071
| +35% | +$3.24M | 0.87% | 37 |
|
|
2020
Q3 | $10.3M | Buy |
40,353
+4,776
| +13% | +$1.18M | 0.97% | 27 |
|
|
2020
Q2 | $8.39M | Buy |
35,577
+1,467
| +4% | +$335K | 0.9% | 39 |
|
|
2020
Q1 | $6.92M | Buy |
34,110
+269
| +0.8% | +$58.8K | 0.98% | 28 |
|
|
2019
Q4 | $8.16M | Sell |
33,841
-141
| -0.4% | -$31.1K | 0.95% | 30 |
|
|
2019
Q3 | $6.58M | Buy |
33,982
+23,663
| +229% | +$4.54M | 0.81% | 50 |
|
|
2019
Q2 | $1.9M | Sell |
10,319
-485
| -4% | -$86.8K | 0.24% | 89 |
|
|
2019
Q1 | $2.05M | Sell |
10,804
-185
| -2% | -$35.3K | 0.27% | 89 |
|
|
2018
Q4 | $2.14M | Sell |
10,989
-45
| -0.4% | -$8.78K | 0.31% | 85 |
|
|
2018
Q3 | $2.29M | Sell |
11,034
-2,836
| -20% | -$559K | 0.28% | 84 |
|
|
2018
Q2 | $2.56M | Buy |
13,870
+2,365
| +21% | +$418K | 0.32% | 82 |
|
|
2018
Q1 | $1.96M | Buy |
+11,505
| New | +$2.11M | 0.23% | 88 |
|
|
2016
Q4 | – | Sell |
-4,262
| Closed | -$711K | – | 189 |
|
|
2016
Q3 | $711K | Sell |
4,262
-693
| -14% | -$117K | 0.04% | 224 |
|
|
2016
Q2 | $754K | Buy |
4,955
+535
| +12% | +$83.2K | 0.04% | 206 |
|
|
2016
Q1 | $663K | Buy |
+4,420
| New | +$657K | 0.04% | 221 |
|
|
2015
Q2 | – | Sell |
-2,245
| Closed | -$359K | – | 275 |
|
|
2015
Q1 | $359K | Sell |
2,245
-75
| -3% | -$11.8K | 0.02% | 252 |
|
|
2014
Q4 | $370K | Sell |
2,320
-1,685
| -42% | -$263K | 0.02% | 250 |
|
|
2014
Q3 | $563K | Sell |
4,005
-90
| -2% | -$11.8K | 0.03% | 230 |
|
|
2014
Q2 | $485K | Sell |
4,095
-530
| -11% | -$61.4K | 0.03% | 231 |
|
|
2014
Q1 | $570K | Sell |
4,625
-80
| -2% | -$9.7K | 0.03% | 229 |
|
|
2013
Q4 | $537K | Buy |
4,705
+134
| +3% | +$15.2K | 0.03% | 230 |
|
|
2013
Q3 | $512K | Sell |
4,571
-145
| -3% | -$15.7K | 0.03% | 238 |
|
|
2013
Q2 | $465K | Buy |
+4,716
| New | +$489K | 0.03% | 241 |
|
Other funds holding AMGN
FFM
SP
Boston Common Asset Management's AMGN Position: Q2 2026 in Review
Boston Common Asset Management reduced its Amgen (AMGN) stake by 54% in Q2 2026, selling an estimated $5.46M and leaving 13,698 shares worth $4.96M. The position accounts for 0.29% of the portfolio, ranked #92.
Boston Common Asset Management first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.8M in Q2 2022. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Boston Common Asset Management held 13,698 shares of Amgen worth $4.96M as of Q2 2026.
- Boston Common Asset Management sold 15,942 Amgen shares in Q2 2026, an estimated $5.46M.
- Amgen made up 0.29% of Boston Common Asset Management's portfolio in Q2 2026, its #92 holding.
- Boston Common Asset Management first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- Boston Common Asset Management's Amgen position peaked at $22.8M in Q2 2022.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.